Literature DB >> 25787227

Access and use of psychotropic medicines in low-resource settings.

C Barbui1.   

Abstract

Improving access and rational use of essential medicines at all levels of care is a global challenge. Key issues related to the provision and rational use of psychotropic medicines have recently been analysed by Padmanathan et al. who conducted a survey of the psychotropic medicines management cycle in Bihar, the third most populous state of India with approximately 104 million people, of whom 88.7% live in rural areas. It was found that availability, distance and cost were the main barriers to access and utilisation. Travelling was reported to be particularly problematic because it is expensive and may also be unfeasible for service users who are acutely ill. In this commentary, the results of this survey are discussed in view of their global policy implications for low-resource settings.

Entities:  

Keywords:  Low- and middle-income countries; psychotropic medicines; rational use

Year:  2015        PMID: 25787227      PMCID: PMC6998629          DOI: 10.1017/S2045796015000268

Source DB:  PubMed          Journal:  Epidemiol Psychiatr Sci        ISSN: 2045-7960            Impact factor:   6.892


  14 in total

Review 1.  Mental health and psychosocial support in humanitarian settings: linking practice and research.

Authors:  Wietse A Tol; Corrado Barbui; Ananda Galappatti; Derrick Silove; Theresa S Betancourt; Renato Souza; Anne Golaz; Mark van Ommeren
Journal:  Lancet       Date:  2011-10-16       Impact factor: 79.321

2.  Broadening the scope of epidemiology in conflict-affected settings: opportunities for mental health prevention and promotion.

Authors:  W A Tol; S J Rees; D M Silove
Journal:  Epidemiol Psychiatr Sci       Date:  2013-09       Impact factor: 6.892

3.  Ensuring access to psychotropic medication in sub-Saharan Africa.

Authors:  J Eaton
Journal:  Afr J Psychiatry (Johannesbg)       Date:  2008-08

4.  What is the WHO essential medicines list?

Authors:  M Purgato; C Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2012-07-30       Impact factor: 6.892

5.  Decisions on WHO's essential medicines need more scrutiny.

Authors:  Corrado Barbui; Marianna Purgato
Journal:  BMJ       Date:  2014-07-31

6.  Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders.

Authors:  Corrado Barbui; Tarun Dua; Mark van Ommeren; M Taghi Yasamy; Alexandra Fleischmann; Nicolas Clark; Graham Thornicroft; Suzanne Hill; Shekhar Saxena
Journal:  PLoS Med       Date:  2010-08-31       Impact factor: 11.069

7.  Risk of post-traumatic stress disorder following traumatic events in a community sample.

Authors:  J White; J Pearce; S Morrison; F Dunstan; J I Bisson; D L Fone
Journal:  Epidemiol Psychiatr Sci       Date:  2014-03-17       Impact factor: 6.892

8.  Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations.

Authors:  Tarun Dua; Corrado Barbui; Nicolas Clark; Alexandra Fleischmann; Vladimir Poznyak; Mark van Ommeren; M Taghi Yasamy; Jose Luis Ayuso-Mateos; Gretchen L Birbeck; Colin Drummond; Melvyn Freeman; Panteleimon Giannakopoulos; Itzhak Levav; Isidore S Obot; Olayinka Omigbodun; Vikram Patel; Michael Phillips; Martin Prince; Afarin Rahimi-Movaghar; Atif Rahman; Josemir W Sander; John B Saunders; Chiara Servili; Thara Rangaswamy; Jürgen Unützer; Peter Ventevogel; Lakshmi Vijayakumar; Graham Thornicroft; Shekhar Saxena
Journal:  PLoS Med       Date:  2011-11-15       Impact factor: 11.069

9.  The role of health systems factors in facilitating access to psychotropic medicines: a cross-sectional analysis of the WHO-AIMS in 63 low- and middle-income countries.

Authors:  Ryan McBain; Daniel J Norton; Jodi Morris; M Taghi Yasamy; Theresa S Betancourt
Journal:  PLoS Med       Date:  2012-01-31       Impact factor: 11.069

10.  World Health organization guidelines for management of acute stress, PTSD, and bereavement: key challenges on the road ahead.

Authors:  Wietse A Tol; Corrado Barbui; Jonathan Bisson; Judith Cohen; Zeinab Hijazi; Lynne Jones; Joop T V M de Jong; Nicola Magrini; Olayinka Omigbodun; Soraya Seedat; Derrick Silove; Renato Souza; Athula Sumathipala; Lakshmi Vijayakumar; Inka Weissbecker; Douglas Zatzick; Mark van Ommeren
Journal:  PLoS Med       Date:  2014-12-16       Impact factor: 11.069

View more
  2 in total

1.  Mapping actions to improve access to medicines for mental disorders in low and middle income countries.

Authors:  C Barbui; T Dua; K Kolappa; B Saraceno; S Saxena
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-09       Impact factor: 6.892

2.  Calling for policy actions to increase access to long-acting antipsychotics in low-income and middle-income countries.

Authors:  Giovanni Ostuzzi; Chiara Gastaldon; Davide Papola; Corrado Barbui
Journal:  Epidemiol Psychiatr Sci       Date:  2022-05-11       Impact factor: 7.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.